» Articles » PMID: 18451249

Treatment of Radioresistant Stem-like Esophageal Cancer Cells by an Apoptotic Gene-armed, Telomerase-specific Oncolytic Adenovirus

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2008 May 3
PMID 18451249
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Radioresistance may be caused by cancer stem cells (CSC). Because CSCs require telomerase to proliferate, a telomerase-specific oncolytic adenoviral vector carrying apoptotic tumor necrosis factor-related apoptosis-inducing ligand and E1A gene (Ad/TRAIL-E1) may preferentially target CSCs.

Experimental Design: We established two pairs of parental and radioresistant (R) esophageal carcinoma cell lines (Seg-1, Seg-1R and TE-2, TE-2R) by fractionated irradiation. Stem cell markers were measured by Western blotting and flow cytometry. Serial sorting was used to enrich stem-like side population cells. Telomerase activity, transgene expression, antitumor activity, apoptosis induction, and viral replication were determined in vitro and/or in vivo.

Results: Expression of the stem cell markers beta-catenin, Oct3/4, and beta(1) integrin in Seg-1R cells was 29.4%, 27.5%, and 97.3%, respectively, compared with 4.8%, 14.9%, and 45.3% in Seg-1 cells (P < 0.05). SP levels in Seg-1R and TE-2R cells were 14.6% and 2.7%, respectively, compared with 3.4% and 0.3% in Seg-1 and TE-2 cells. Serial sorting of Seg-1R SP cells showed enrichment of the SP cells. Telomerase activities in Seg-1R, Seg-1R SP, and TE-2R cells were significantly higher than in Seg-1, Seg-1R non-SP, and TE-2 cells, respectively (P < 0.05). Seg-1R and TE-2R cells were more sensitive to Ad/TRAIL-E1 than parental cells. Increased Coxsackie-adenovirus receptor and elevated transgene expressions were found in the radioresistant cells. Ad/TRAIL-E1 resulted in significant tumor growth suppression and longer survival in Seg-1R-bearing mice (P < 0.05) with no significant toxicity.

Conclusion: Radioresistant cells established by fractionated irradiation display CSC-like cell properties. Ad/TRAIL-E1 preferentially targets radioresistant CSC-like cells.

Citing Articles

Aldo-keto reductase family 1 member C3 mediates radioresistance of esophageal cancer cells through suppressing MAPK and AKT signaling.

Xiong W, Xie Y, Wang D, Huang X, Hao X, Liu J BMC Cancer. 2024; 24(1):1236.

PMID: 39375680 PMC: 11459825. DOI: 10.1186/s12885-024-13012-z.


The role of oncolytic virotherapy and viral oncogenes in the cancer stem cells: a review of virus in cancer stem cells.

Faghihkhorasani A, Dalvand A, Derafsh E, Tavakoli F, Younis N, Yasamineh S Cancer Cell Int. 2023; 23(1):250.

PMID: 37880659 PMC: 10599042. DOI: 10.1186/s12935-023-03099-y.


Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies.

An J, Hu X, Liu F Front Oncol. 2023; 13:1114621.

PMID: 36910604 PMC: 9996315. DOI: 10.3389/fonc.2023.1114621.


The lipid rafts in cancer stem cell: a target to eradicate cancer.

Zhang S, Zhu N, Li H, Gu J, Zhang C, Liao D Stem Cell Res Ther. 2022; 13(1):432.

PMID: 36042526 PMC: 9429646. DOI: 10.1186/s13287-022-03111-8.


Induction and assessment of persistent radioresistance in murine leukocytes .

Morales-Ramirez P, Cruz-Vallejo V, Vallarino-Kelly T, Rodriguez-Reyes R, Gonzalez-Beltran F Biochem Biophys Rep. 2022; 31:101296.

PMID: 35707716 PMC: 9189778. DOI: 10.1016/j.bbrep.2022.101296.


References
1.
Pearson A, Koch P, Atkinson N, Xiong M, Finberg R, Roth J . Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines. Clin Cancer Res. 2000; 5(12):4208-13. View

2.
Chang J, Zhang X, Komaki R, Cheung R, Fang B . Tumor-specific apoptotic gene targeting overcomes radiation resistance in esophageal adenocarcinoma. Int J Radiat Oncol Biol Phys. 2006; 64(5):1482-94. PMC: 1458528. DOI: 10.1016/j.ijrobp.2005.11.045. View

3.
Poste G, Tzeng J, Doll J, Greig R, RIEMAN D, ZEIDMAN I . Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases. Proc Natl Acad Sci U S A. 1982; 79(21):6574-8. PMC: 347170. DOI: 10.1073/pnas.79.21.6574. View

4.
Hadnagy A, Gaboury L, Beaulieu R, Balicki D . SP analysis may be used to identify cancer stem cell populations. Exp Cell Res. 2006; 312(19):3701-10. DOI: 10.1016/j.yexcr.2006.08.030. View

5.
Clarke M, Dick J, Dirks P, Eaves C, Jamieson C, Jones D . Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006; 66(19):9339-44. DOI: 10.1158/0008-5472.CAN-06-3126. View